FORTIS
Healthcare FacilitiesFortis Healthcare Ltd
Its registered office was originally located at 25, Nehru Place, New Delhi 110 019, India. According to a Board resolution as of September 16, 2003, and then the registered office was being shifted to B- 9, Maharani Bagh, New Delhi 110 065, India. Soon after, according to the Board resolution as of February 10, 2006, then the registered office of the company was being shifted to Piccadily House, 275- 276, 4th Floor, Captain Gaur Marg, Srinivas Puri, New Delhi 110 065, India that is also the current Registered Office.
June 2001: The commissioning of Fortis Hospital, Mohali took place.
August 2003: The inauguration and commissioning of Fortis Hospital, Amritsar took place.
October 2003: It executed an agreement with Seth Jessa Ram as well as Bros Charitable Hospital Trust for both the operation and management of Jessa Ram Hospital, New Delhi.
August 200: Also, the commissioning of Fortis Hospital, Noida.
September 2005: It acquired 90% of the equity share capital of the Escorts Heart Institute and Research Centre Limited that resulted in the acquisition of EHSSIL, EHCL, EHSSHL, and EHRCL.
- Trades at a P/E of 63, with a return on equity (ROE) of 7.85%.
- FORTIS is trading above 2 of 5 of its key moving averages (10/20/50/100/200-DMA) — a bearish technical setup.
- Year-to-date it is up 7.48%, and up 1.34% over the past year.
- At ₹948.70 it sits about 54% of the way up its 52-week range (₹766.80–₹1,104.30).
- Offers a dividend yield of 0.21%.
- Market capitalisation stands at ₹71,784 Cr.
Shareholding data syncs daily.
| Year | Revenue | Net Profit | EPS | NPM |
|---|---|---|---|---|
| Mar 2023 | ₹1,053 Cr | ₹96 Cr | ₹1.27 | 9.12% |
| Mar 2022 | ₹863 Cr | ₹-13.00 Cr | ₹-0.18 | -1.51% |
| Mar 2021 | ₹4,030 Cr | ₹-110.00 Cr | ₹-1.45 | -2.73% |
| Mar 2021 | ₹4,030 Cr | ₹-110.00 Cr | ₹-1.45 | -2.73% |
| Mar 2020 | ₹4,632 Cr | ₹58 Cr | ₹0.77 | 1.25% |
| Mar 2020 | ₹4,632 Cr | ₹58 Cr | ₹0.77 | 1.25% |
| Mar 2019 | ₹4,469 Cr | ₹-299.00 Cr | ₹0.00 | -6.69% |
| Mar 2019 | ₹4,469 Cr | ₹-299.00 Cr | ₹0.00 | -6.69% |
| Mar 2018 | ₹4,561 Cr | ₹-1009.00 Cr | ₹0.00 | -22.12% |
| Mar 2017 | ₹4,574 Cr | ₹422 Cr | ₹8.14 | 9.23% |
| Mar 2016 | ₹4,199 Cr | ₹18 Cr | ₹0.40 | 0.43% |
| Mar 2015 | ₹3,966 Cr | ₹-144.00 Cr | ₹0.00 | -3.63% |
| Company | P/E | Book Value | Sales Growth |
|---|---|---|---|
| INDRAMEDCO INDRAPRASTHA MEDICAL CORP.LTD. | 9.48 | ₹27.47 | 1.42% |
| APOLLOHOSP APOLLO HOSPITALS ENTERPRISE LTD. | 69.11 | ₹266.77 | 14.71% |
| MAXHEALTH Max Healthcare Institute Ltd | 650 | ₹0.00 | — |
| KIMS Krishna Institute of Medical Sciences Limited | 51.7 | ₹113.00 | — |
| NH Narayana Hrudayalaya Ltd | 86.73 | ₹57.42 | 12.21% |
| SHALBY Shalby Ltd | 22.46 | ₹76.16 | 0% |
| HCG HealthCare Global Enterprises Ltd | 0 | ₹74.60 | 10.78% |
| Date | Client | Type | Qty | Price |
|---|---|---|---|---|
| 25 Oct 2022 | ISHARES CORE EMERGING MARKETS MAURITIUS CO | SALE | 5,53,352 | ₹272.80 |
| 25 Oct 2022 | ISHARES CORE MSCI EMERGING MARKETS ETF | PURCHASE | 5,53,352 | ₹272.80 |
| 25 Oct 2022 | ISHARES INDIA SC MAURITIUS COMPANY | SALE | 2,42,116 | ₹272.80 |
| 25 Oct 2022 | ISHARES MSCI INDIA SMALL-CAP ETF | PURCHASE | 2,42,116 | ₹272.80 |
| 17 Oct 2022 | ISHARES CORE EMERGING MARKETS MAURITIUS CO | SALE | 8,69,515 | ₹274.20 |
| 17 Oct 2022 | ISHARES CORE MSCI EMERGING MARKETS ETF | PURCHASE | 8,69,515 | ₹274.20 |
| 17 Oct 2022 | ISHARES INDIA SC MAURITIUS COMPANY | SALE | 1,20,971 | ₹274.20 |
| 17 Oct 2022 | ISHARES MSCI INDIA SMALL-CAP ETF | PURCHASE | 1,20,971 | ₹274.20 |
| 11 Oct 2022 | ISHARES CORE EMERGING MARKETS MAURITIUS CO | SALE | 6,37,692 | ₹271.40 |
| 11 Oct 2022 | ISHARES CORE MSCI EMERGING MARKETS ETF | PURCHASE | 6,37,692 | ₹271.40 |
| 11 Oct 2022 | ISHARES INDIA SC MAURITIUS COMPANY | SALE | 88,717 | ₹271.40 |
| 11 Oct 2022 | ISHARES MSCI INDIA SMALL-CAP ETF | PURCHASE | 88,717 | ₹271.40 |
Fundamentals, financials & technicals sourced from niftytrader.in, cached and refreshed periodically.